Physician profile
Kim Le Alt
NPI 1720236680
$1,249.96
in general payments reported to CMS, 2019-2025
18 companies · $368 in 2025
The $368 reported for 2025 was more than what 89% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.93 · 2020: $73.00 · 2021: $264 · 2022: $124 · 2023: $104 · 2024: $237 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $708.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $168.23 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Takeda Pharmaceuticals U.S.A., INC. | $137.76 | 2020-2021 | |
| Pfizer INC. | $111.67 | 2022-2025 | |
| Cranial Technologies, INC | $90.58 | 2022-2025 | Doc Band |
| Seqirus USA INC | $87.05 | 2021-2024 | Flucelvax Quadrivalent, Flucelvax |
| Collegium Pharmaceutical, INC. | $80.32 | 2025 | Jornay Pm |
| Kaleo, INC. | $78.55 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $76.31 | 2024-2025 | |
| Sanofi Pasteur INC. | $67.57 | 2019-2024 | |
| Corium, LLC | $62.24 | 2025 | Azstarys |
| Ars Pharmaceuticals Operations, INC. | $58.23 | 2025 | Neffy |
| Phadia US INC. | $53.39 | 2020-2021 | |
| Glaxosmithkline, LLC. | $50.30 | 2021-2025 | Bexsero |
| Supernus Pharmaceuticals, INC. | $49.77 | 2023-2024 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $27.80 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cognoa, INC. | $23.81 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.65 | 2025 | Zoryve |
| Shire North American Group INC | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Alt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.